These press releases are intended for business journalists and analysts/ investors. Please note that these releases may not have been issued in every market in which GSK operates.
[an error occurred while processing this directive] [an error occurred while processing this directive]02 September 2010
Reports of narcolepsy in Europe following vaccination with Pandemrix™
30 August 2010
GSK and Valeant announce new U.S. FDA PDUFA goal date for ezogabine
24 August 2010
GSK European Commission amends licence for Cervarix®
> News on Avandia (rosiglitazone maleate)
> Data published in Nature offers promising options to explore
> Information related to the 2009 outbreak of H1N1 flu
View and download our results announcement, along with the related webcast and presentation.
GSK's strategic priorities
View and download images from our photo library.
PC hi-res version 1,113k
PC hi-res version 1,417k
PC hi-res version 1,495k
PC hi-res version 1,419k
PC hi-res version 971k
PC hi-res version 1,191k
View photo library
Our R&D organisation measures
productivity by the number and
innovation of the products it creates,
and also by the commercial value of
the products.
More about our product pipeline Share price